The primary process established by the European Commission to address the science needed to define key REACH concepts and to help rationally implement REACH's ambitions is enshrined in a series of activities known as the REACH Implementation Projects (RIPs). These are projects that aim to define the methodology that could be used, and present the basis for guidance on the actual principles and procedures that may be (are proposed to be) followed in the development of the required documentation that ensures the safe use of chemicals. In order to develop soundly based and equitable regulation, it is necessary that science governance using established and accepted scientific principles must take a leading role. The extent to which such governance is embraced will be determined by many factors, but notably the process adopted to enable scientific discussion to take place. This article addresses the issues of science as they have impacted on the exemplification of the Exposure Scenario concept under REACH. The current RIP activities have created a non-adversarial process in which the key stakeholders are able to discuss the key REACH challenges. But the RIP activities will be finalised before REACH comes into force. A suitable mechanism should perhaps now be identified to ensure that this positive spirit of scientific discussion and collaboration can continue to benefit REACH and those that it serves well into the future.
Introduction
The background to and legislative objectives of the REACH package have been described and broadly discussed elsewhere (Christensen et al., 2003) . The ambitions cover policy considerations (such as the reversal of the burden of proof from regulatory agencies to chemical manufacturers and importers), the intention of the regulatory process to address risks throughout the supply chain (and communicate them in an integrated fashion via the safety data sheet (SDS)), the prioritisation and enactment of regulatory enforcement policies based, in part, on considerations of risk, and the application of a holistic approach to the safe use of chemicals across humans and the environment. For any risk-based policy to be developed, its foundations should be firmly based on scientific facts derived from applying established scientific principles and methodologies to risk assessments. In the context of the European Union (EU) regulation on the Registration, Evaluation and Authorisation of Chemicals (REACH), although several new concepts have been introduced, many of the basic principles are already enshrined in existing EU legislation. For example, the Technical Guidance Documents (European Commission, 2003) developed during the course of scientific debate amongst the EU Member States over the last 10-15 years are considered to be a starting point for the application of scientific principles and methodologies for chemicals exposure and risk assessment within REACH. But REACH goes farther than the existing regulation. Indeed, one reason for the introduction of REACH is the perceived failure of that regulatory regimen (Bodar et al., 2003) . Europe has therefore concluded that in addition to fostering a political debate on the content of the REACH regulatory package, there also needs to be a parallel discussion that addresses the key scientific challenges presented by REACH, together with accompanying consideration of the practicability (for both industry and the regulatory community) of the proposed process of implementation.
Scientific Governance in the Development of Public Policy
The primary process established by the European Commission to provide the guidance needed to interpret key REACH concepts and to help rationally implement REACH's ambitions is the series of activities known as the REACH Implementation Projects (RIPs). The RIPs are expected to address scientific developments and incorporate them into the guidance, if technically achievable and scientifically founded. The RIPs cover a variety of topics ranging from the consistent characterisation of key end points through intelligent testing strategies, through the process of exposure and risk assessment to the overall information technology framework and platform upon which REACH might be expected to operate efficiently. As far as human and environmental exposure assessment is concerned, however, the discussion has been confined to the activities of RIP 3.2. This RIP seeks to examine how risk assessments under REACH, termed chemical safety assessments (CSAs), should be carried out and communicated along the relevant industry chains (and elsewhere), although it only foresees the use of material SDSs as the means to achieve that goal.
REACH introduces a particular use of the term 'Exposure Scenario' as the core mechanism through which health and environmental risks are evaluated and risk management measures communicated. While the concept of the exposure scenario is not new and has been previously defined (IPCS, 2001; OECD, 2003a) , in the case of REACH, the exposure scenario is taken to mean ''the set of conditions that describe how a substance is manufactured or used during its life cycle and how the manufacturer or importer controls, or recommends, downstream users to control exposures of humans and the environment''. This study addresses the issues of science as they have impacted on the exemplification of the Exposure Scenario under REACH.
Discussion
It is generally accepted that science governance using established and accepted scientific principles must have a pivotal role in the definition and development of regulatory policies that seek to achieve health and environmental objectives (Bradbury et al., 2004) . As a consequence, it therefore appears reasonable to assume that in order that any successful policy can be developed, suitable opportunities will be provided to stimulate and solicit relevant scientific discussion and input. Regulation generally consists of a framework of legislation supported by relevant technical guidance. Because of the high political profile that REACH has taken in Europe, there has been an understandable reticence in some quarters to engage openly in scientific discussions that might either stray beyond the scope of the envisaged legislation or potentially challenge the (often hard to achieve) political consensus surrounding its genesis. Furthermore, the opportunities for fundamental discussion have been affected by the milestones that are defined by the political process (involving the European Commission, European governments (via the Council of Ministers) and the European Parliament) in which complex regulation is developed and debated. This has resulted in the need at a policy level to manage the discussion, not only within the scope and letter of the developing legislation, but also according to key dates determined by events external to any scientific debate. Thus the scientific discussions that have been allowed within REACH have been shaped more by policy considerations than by the proper application of scientific governance. The limited budget available to fund the various RIPs has further constrained the extent to which supporting research, verification, and consultation activities have been able to take place to underpin the integrity and practicality of these projects. This is unfortunate, but perhaps not unique, amongst mechanisms of regulatory development.
A further major challenge has been created by the scope of REACH's ambitions. REACH applies to all manufacturers, importers and users of chemicals in Europe, and covers the risks that can occur throughout the chemicals supply chain. Although it may be comparatively straightforward to set, from the perspective of the regulator, broad common objectives that relate to the responsibility of affected groups to manage human and environmental risks, identifying and implementing a framework that is sufficiently robust while remaining understandable and workable has created paradoxes in some areas. REACH lays down far-reaching responsibilities that go beyond the established management control boundaries of the companies involved in, or associated with, the chemicals supply chain. For example, smaller companies tend to want to keep their responsibilities straightforward and simple, and to receive risk management guidance that is more ''instruction-oriented'' than empirical (Briggs and Crumbie, 2000) . On the other hand, regulatory agencies, understandably, expect legislative processes to be rigorous and transparent. Rigour and transparency often translate into the need to develop and communicate extensive and detailed documents, whether they relate to financial and business propriety or to the supply and use of chemicals (as in the case of REACH). Similarly, past EU chemicals legislation has placed the responsibility for communicating hazard and safety information on chemical suppliers. In response, most chemical suppliers have established SDS systems as part of their supply-chain management processes. These systems have their limitations, but they are generally understood by all the supply-chain actors (Walters and Grodzki, 2006) . REACH now places the prime responsibilities for communication with manufacturers (and importers into the EU) of chemicals. Because these groups are located further up the supply chain and are hence more remote from contact with (smaller) downstream users of chemicals, it remains to be seen whether shifting (and increasing) the burden of responsibility will substantively benefit those generally most at risk from exposures to chemicals.
Although opportunities have existed within the REACH process for the discussion of the scientific issues concerning how exposure scenarios might be developed, evaluated, and communicated, these opportunities have invariably been affected by the need to also address ''process'' or ''workability'' considerations. While this is understandable, this has meant that the opportunities for scientific discussion have been limited. This contrasts with the mechanisms adopted for some of the major exposure and risk assessment models developed over recent years in Europe and which are currently under discussion as part of REACH (Table 1) . The genesis and development of these models have been varied and each has its technical shortcomings (JRC, 2005) . However, what is clear is that all have undergone significant stakeholder review (by regulatory agencies, trade unions, industry and other interest groups) during their development, where the nature of the discussion has not been constrained either by the requirement to keep within defined scientific boundaries or maintain historical definitions or interpretations.
The process being used to develop and test the scientific processes supporting the RIPs has not had, by comparison, such opportunities. This does not mean to say that the end result will be any less rigorous or less useful; only time and experience will allow such a judgement to be made. It is clear that if considerations of exposure are to play a far greater role under REACH than has been the case under previous EU chemicals legislation, then the practical implications arising from their implementation and communication need to be well understood and elucidated (Fryer et al., 2006) . But it is also apparent that they do not appear to have been given equivalence (at least in the conceptual thinking of REACH) to those relating to hazard and effect assessments. For example, neither REACH nor its supporting IT framework currently envisage the systematic exchange and/or pooling of key exposure information, unlike the improvements to IUCLID (International Uniform Chemical Information Database) that have been developed to facilitate the exchange of effects information and to foster the communication of the Chemical Safety Report. Similarly, while much attention has been paid to harmonising the basis by which effects information will be summarised and communicated in support of the UN-brokered globally harmonised system (GHS), no discussion has yet taken place on a common basis by which exposure and risk management information might be communicated. This is unfortunate, as the preliminary discussions at the international level have identified a tentative basis by which core exposure information could be shared (OECD, 2003b) , and the previous experiences within some EU Member States have regularly demonstrated the value of coherent approaches to collecting and communicating information on core determinants for chemical exposures (Flyvholm, et al., 1992) . While some Member States and industry trade groups will undoubtedly continue to make such exposure information available, it will not constitute a representative picture of chemical exposures in the EU.
In addition to the procedures, tools and guidelines emanating from the RIP activities, the effective implementation of REACH will also demand extensive access to skilled technical resources in the fields of both toxicology and exposure/risk assessment. But the number of skilled professionals is limited at the European regional level and hence is only likely to be addressed by the introduction of suitable training programmes (which have yet to be either defined or introduced as part of REACH). Moreover, the tight implementation timetable foreseen in the legislation may result in the need for pragmatic rather than scientific solutions, which will not be assisted by either the shortcomings in the technical guidance or lack of supporting tools. A major challenge will therefore be to invest in further research, particularly in exposure-scenario building; emission estimation and exposure assessment for different compartments and populations; the relation of these to tiered risk assessment systems; and further clarification of the role that an understanding of exposure can have in shaping and optimising Integrated Testing Strategies under REACH (especially with respect to exposure-based waiving) (JRC, 2004) .
Conclusions
The objectives of the REACH legislative package are ambitious. To achieve these, a mechanism needs to be identified through which consistent and suitable consideration can be made of the exposures arising from the manufacture and use of chemicals. This task is more challenging than it appears at face value, however, because such mechanisms need to have the confidence of and be accessible to all stakeholders (be they regulators, trade unions, consumer groups or industry). The RIPs initiated by the European Commission are well-intentioned and have the potential, provided adequate opportunity is given for the discussion of scientific matters and the application of the necessary science governance principles, to deliver a robust framework upon which to deliver REACH's objectives. To successfully meet this new paradigm, the RIP processes will not only need to respect the aspirations of politicians, but will also need to be receptive to new ideas and solutions. The RIP processes will be finalised in 2007 and much discussion on how considerations of exposure are best addressed has already taken place. But there still remains much to do. In this respect, it is worthy of note that the need for new research programmes in support of intelligent chemicals risk assessment has already been acknowledged by a call for proposals by the European Commission under its 7th framework programme.
If REACH is to meet its stated objectives, including the desire to ensure European industry remaining competitive, then the REACH methodologies will need to be kept under review and revised if appropriate. The collegiate nature of REACH and its supporting guidance, involving dialogue across the supply chain, within workplaces, and across regulatory boundaries, will continue to provide opportunities to test, review, and refine the overall process. The current RIP activities have created a non-adversarial process in which the key stakeholders are able to discuss the key REACH challenges. But the RIP activities will largely be finalised before REACH comes into force. A suitable mechanism should perhaps now be identified to ensure that this positive spirit of scientific discussion and collaboration continues to benefit REACH and those that it serves well into the future.
